Abdominally Targeted Management Exercises for Crohn's Disease Patients (TAME-CD)

Inclusion Criteria: * Patients with no treatment or on constant medicinal therapy, expected to remain constant: mesalamine for at least 6 weeks, steroids at least 2 weeks (≤20mg prednisone or budesonide ≤6mg), immunomodulatory at least 12 weeks or biologics/ small molecules for at least 12 weeks therapy. Patients who initiate the study on steroids will remain on a constant dose throughout the study. * If patients stopped therapy prior to the study then they should be at least 2 weeks from stopping steroids or 5ASA, or 4 weeks from stopping small molecules, 8 weeks from stopping biologics, or 12 weeks from stopping thiopurines. * CD patients will be included if their symptoms score \>4 and ≤15 on the HBI score * Fecal calprotectin\>150ug/gr or evidence of an active disease per IUS defined as increased blood flow (modified Limberg score\>0) or thickness of bowel wall\>3mm Exclusion Criteria: * Inability to commit for performing at least 10-15 minutes of exercise, 6 times a week. * Lack of availability or capability to use a computer/ internet. * Any proven current infection such as, fever, active abscess, Clostridioides difficile infection, positive stool culture, or parasite in patients with chronic diarrhea. * Inability to sign informed consent and/ or complete the study protocol. * Incompetent individuals who are unable to provide informed consent. * Planed pregnancy or pregnancy- up to 3 months post labor. * Subjects with chronic conditions such as active arthritis, canc…